Search results
Jun 26, 2023 · Eli Lilly’s Mounjaro, cleared for type 2 diabetes and awaiting FDA approval for weight loss, targets both GLP-1 and a hormone called GIP, and has produced weight loss of 21 to 23%.
Feb 15, 2024 · This article will discuss eight current Food and Drug Administration (FDA)–approved weight loss drugs on the market.
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
The table below lists prescription drugs approved by the FDA for weight loss. The FDA has approved five of these drugs—orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), liraglutide (Saxenda), and semaglutide (Wegovy)—for long-term use.
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the wildly popular Wegovy. The drug is called tirzepatide and...
The FDA approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition, for use in addition to a...
Oct 29, 2022 · Six weight-loss drugs have been approved by the U.S. Food and Drug Administration (FDA) for long-term use: Bupropion-naltrexone (Contrave) Liraglutide (Saxenda)
Yes, there are several other weight loss products are approved by the FDA. Saxenda (liraglutide) is also a glucagon-like peptide-1 (GLP-1) receptor agonist injection and is approved for chronic weight management in adults and children 12 years of age and older.
Apr 1, 2024 · Some popular weight-loss pills are Contrave (naltrexone / bupropion), Qsymia (phentermine / topiramate ER), and phentermine (Adipex-P). Some clinical studies suggest that Qsymia is the most effective weight loss pill. However, it’s a controlled substance that may not be the best option for everyone.
Jun 10, 2021 · The FDA on Friday approved a new weight-loss drug, Wegovy, for people who are either obese or overweight and have at least one weight-related medical problem.
